Tag: Breaking News: Business

Weight loss drugs could be a gamechanger for women with a common hormonal disorder

July 21, 2025 Admin No Comments

Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg | Getty Images For well over a decade, Grace Hamilton, 27, experienced hair loss, heavy periods, infrequent menstrual cycles, mental health issues and difficulty losing weight without knowing why. It wasn’t until 2023 when she was diagnosed with…

Health

Medicaid cuts in Trump’s ‘big beautiful bill’ will leave millions uninsured, threaten rural hospitals

July 2, 2025 Admin No Comments

An aerial view of Valley Health Hampshire Memorial Hospital on June 17, 2025 in Romney, W.V. Ricky Carioti | The Washington Post | Getty Images President Donald Trump‘s “big beautiful bill” would make sweeping changes to U.S. health care, leaving millions of vulnerable Americans without health insurance and threatening the hospitals and centers that provide…

Health

Anne Wojcicki to buy back 23andMe and its data for $305 million

June 13, 2025 Admin No Comments

23andMe founder Anne Wojcicki speaks during a House Committee on Oversight and Government Reform hearing in Washington, D.C., on June 10, 2025. Andrew Harnik | Getty Images Anne Wojcicki, the co-founder and former CEO of 23andMe, has regained control over the embattled genetic testing company after her new nonprofit, TTAM Research Institute, outbid Regeneron Pharmaceuticals,…

Health

Trump wants to slash U.S. drug prices with ‘most favored nation’ policy – here’s what to know

May 12, 2025 Admin No Comments

President Donald Trump, joined by National Institutes of Health (NIH) Director Jay Bhattacharya, speaks during a press conference in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC. Andrew Harnik | Getty Images News | Getty Images President Donald Trump on Monday moved forward with a plan to lower U.S….

Health

Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound

April 4, 2025 Admin No Comments

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Reuters President Donald Trump on Friday dropped a Biden administration proposal to have Medicare cover obesity drugs, including popular but costly GLP-1 treatments such as Novo Nordisk‘s Wegovy and Eli Lilly‘s Zepbound. But the Centers…

Health

Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

November 26, 2024 Admin No Comments

The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty Images Amgen on Tuesday said its experimental weight loss injection helped patients with obesity lose up to 20% of their weight on average after a year in a critical mid-stage trial, as the company races…

Health

What McDonald’s needs to do next after E. coli outbreak

October 25, 2024 Admin No Comments

In this photo illustration, a McDonald’s Quarter Pounder hamburger meal is seen at a McDonald’s on October 23, 2024 in the Flatbush neighborhood in the Brooklyn borough of New York City. Michael M. Santiago | Getty Images As McDonald’s and health authorities race to contain a deadly E. coli outbreak, the burger chain faces challenges…

Health

FTC sues drug middlemen for allegedly inflating insulin prices

September 21, 2024 Admin No Comments

Lina Khan, Chair of the Federal Trade Commission (FTC), testifies before the House Appropriations Subcommittee at the Rayburn House Office Building on May 15, 2024 in Washington, DC. Kevin Dietsch | Getty Images News | Getty Images The Federal Trade Commission on Friday sued three large U.S. health companies that negotiate insulin prices, arguing the…

Health

Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trial

August 20, 2024 Admin No Comments

Eli Lilly’s highly popular weight loss drug reduced the risk of developing Type 2 diabetes by 94% in obese or overweight adults with prediabetes compared with a placebo, according to initial results from a long-term study released Tuesday. The late-stage trial on tirzepatide, the active ingredient in the company’s weight loss injection Zepbound and diabetes…

Health

Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says

August 2, 2024 Admin No Comments

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters All doses of Eli Lilly’s highly popular weight loss injection Zepbound and diabetes drug Mounjaro are now available in the U.S., according to an update on the U.S. Food and Drug…

Health